Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Inv. presentation
Acq. announced
Director departure
Appointed director
|
|
Emmaus Life Sciences, Inc. (MYND)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/31/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 05/03/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 01/22/2021 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 12/11/2018 |
10-K
| Annual Report for the period ended September 30, 2018 |
| 12/29/2017 |
10-K
| Annual Report for the period ended September 30, 2017 |
| 12/22/2016 |
10-K
| Annual Report for the period ended September 30, 2016 |
| 01/05/2016 |
10-K
| Annual Report for the period ended September 30, 2015 |
| 12/29/2014 |
10-K
| Annual Report for the period ended September 30, 2014 |
| 12/23/2013 |
10-K
| Annual Report for the period ended September 30, 2013 |
| 01/15/2013 |
10-K
| Annual Report for the period ended September 30, 2012 |
| 12/22/2011 |
10-K
| Annual Report for the period ended September 30, 2011 |
| 12/21/2010 |
10-K
| Annual Report for the period ended September 30, 2010 |
| 12/30/2009 |
10-K
| Annual Report for the period ended September 30, 2009 |
| 01/13/2009 |
10-K
| Annual Report for the period ended September 30, 2008 |
|
|